Cetera Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,519
Closed -$532K 58
2017
Q2
$532K Sell
16,519
-3,449
-17% -$109K 0.67% 39
2017
Q1
$648K Sell
19,968
-9,861
-33% -$311K 0.74% 40
2016
Q4
$919K Sell
29,829
-8,208
-22% -$251K 0.69% 54
2016
Q3
$1.22M Sell
38,037
-4,224
-10% -$141K 0.79% 39
2016
Q2
$1.41M Sell
42,261
-4,383
-9% -$140K 0.83% 35
2016
Q1
$1.31M Sell
46,644
-1,851
-4% -$52.9K 0.68% 51
2015
Q4
$1.49M Buy
+48,495
New +$1.53M 0.6% 59

Other funds holding PFE

Cetera Investment Management's PFE Position: Q3 2017 in Review

Cetera Investment Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 16,519 shares — an estimated $532K sold.

Cetera Investment Management first reported a position in PFE in Q4 2015 and held it in 7 quarters. The position peaked at $1.49M in Q4 2015. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Cetera Investment Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Cetera Investment Management sold 16,519 Pfizer shares in Q3 2017, an estimated $532K.
  • Cetera Investment Management first reported a position in Pfizer in Q4 2015 and held it in 7 quarters.
  • Cetera Investment Management's Pfizer position peaked at $1.49M in Q4 2015.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Cetera Investment Management's 13F filing for Q3 2017.